4//SEC Filing
Sharp John P 4
Accession 0001209191-19-032659
CIK 0001169245other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 2:22 PM ET
Size
7.2 KB
Accession
0001209191-19-032659
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Exercise/Conversion
Common Stock
2019-05-22$1.69/sh+15,000$25,350→ 20,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-22−15,000→ 120,582 totalExercise: $1.69Exp: 2026-05-12→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from March 1, 2016, subject to the reporting person's continued service through each such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001342894
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 2:22 PM ET
- Size
- 7.2 KB